Your OB-GYN will walk with you through these changes to help you manage them
What else can I do to get coverage
consumers should review OpenLoop's telehealth consent at openloophealth.com/telehealth-consent and ask FeelGood support specific data privacy questions before enrollment FDA compounded GLP-1 adverse events: The FDA received 1,150+ adverse event reports related to compounded semaglutide/tirzepatide as of July 2025, including dosing errors with vial-based injectables
Not approved by FDA, EMA or as of 2026
Kelly Broster, Senior Manager of Market Development and Collaborations at Thermo Fisher Scientific, whose 15+ years of hands-on LC-MS experience spans cancer biology, quantitative proteomics, and biomarker assays, addressed the high-resolution mass spectrometry and integrated workflow dimensions
Both peptides have unique effects on the human growth hormone axis